Rendiatech
Real-time Renal Diagnostics
Company Overview
Snapshot
Founded in June 2009 by Avi Kleiman and Mor Grinstein, Rendiatech operates with 1–10 employees. The company has secured $29.83M across five funding rounds and one grant. In August 2025, Rendiatech was acquired by Nuwellis.
Business overview
Rendiatech is a medical device company focused on real-time renal diagnostics. Its core product, Clarity RMS, is a critical care monitoring system designed for early detection of changes in renal function and acute kidney injury (AKI) risk, as well as treatment monitoring. The system provides continuous, automatic urine flow monitoring and additional real-time parameters to enhance critical care management in ICUs and perioperative settings. Rendiatech serves the healthcare industry, specifically hospitals and medical centers globally, operating within the Health Tech & Life Sciences sector, with a focus on medical devices, diagnostics, and monitoring technologies.
Strategic signal
In August 2025, Rendiatech was acquired by Nuwellis. This acquisition signals a strategic move to integrate Rendiatech's real-time renal diagnostics into a larger medical technology portfolio, potentially accelerating market penetration and product development. For investors, this indicates a successful exit for Rendiatech's early backers and validates the commercial potential of its Clarity RMS system in critical care.
Log in to access full profile ›Company Intelligence Q&A
- What is Rendiatech's primary product?
- Rendiatech's primary product is Clarity RMS, a critical care monitoring system that provides continuous, automatic monitoring of urine flow and other real-time parameters for early detection of changes in renal function and acute kidney injury (AKI) risk.
- When was Rendiatech acquired?
- Rendiatech was acquired by Nuwellis in August 2025.
- Did Rendiatech receive any grants?
- In May 2019, Rendiatech secured a grant from the Israel Innovation Authority.
- When did Rendiatech obtain CE Mark for its Clarity RMS system?
- Rendiatech obtained CE Mark for its Clarity RMS critical care system in August 2019.